Biogend Therapeutics Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Biogend Therapeutics Co Ltd

Watchlist Manager

Watchlist

Price: 25.5 TWD -0.97% Market Closed

Market Cap: NT$3.4B

B	Biogend Therapeutics Co Ltd TPEX:6733	TW
	Pariksha Fin-Invest Lease Ltd BSE:539481	IN
	Waverley Pharma Inc XTSX:WAVE	CA
	Icetana Ltd ASX:ICE	AU
E	Etoiles Capital Group Co Ltd NASDAQ:EFTY	HK
	Contextlogic Inc NASDAQ:LOGC	US
	Gold River Productions Inc OTC:GRPS	US
E	Eko Export SA WSE:EEX	PL
T	Tinka Resources Ltd XBER:TLD	CA
	ALM. Brand A/S CSE:ALMB	DK
	Jackpot Digital Inc XTSX:JJ	CA
C	Connections Consult SA XBSE:CC	RO
	United Foodbrands Ltd NSE:UFBL	IN
U	Ucb SA DUS:UNC	BE

Profitability Summary

Biogend Therapeutics Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

71%

Strong 3Y Average Gross Margin

77%

Declining Gross Margin

80% > 71%

Negative Operating Margin

-39%

Negative 3Y Average Operating Margin

-92%

Operating Margin is Increasing

-297% > -39%

Negative Net Margin

-29%

Negative 3Y Average Net Margin

-80%

Net Margin is Increasing

-267% > -29%

Negative Free Cash Flow Margin

-21%

Negative 3Y Average Free Cash Flow Margin

-76%

Free Cash Flow Margin is Increasing

-298% > -21%

Negative ROE

-7%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-41%

ROIC is Increasing

-64% > -31%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.